Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=108"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=108

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT05168813-1bc0a9aa",
        "title": "Part B (Blinded): mRNA-1273 at Month 6 vs Part B (Blinded): mRNA-1273.222 at Month 6: Part B: Number of Participants With a First Occurrence of CDC-based COVID-19 Starting 14 Days After Month 6 Dose Until End of Follow up in RM6 Cohort Between Month 6 Monovalent and Bivalent Boost Groups",
        "summary": "151 of 1976 against 142 of 2012; risk difference 0.6 points, 95% interval -1.0 to 2.2; NCT05168813, Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern",
        "record": "/library/comparisons/NCT05168813-1bc0a9aa",
        "nct_id": "NCT05168813",
        "kind": "outcome",
        "participants": 3988,
        "risk_difference": {
          "value": 0.0058404632931158,
          "lower": -0.010398267347622156,
          "upper": 0.022136695903160374
        },
        "group_1": "151 of 1,976",
        "group_2": "142 of 2,012",
        "difference": "0.6 points",
        "interval": "-1.0 to 2.2",
        "trial_title": "Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern"
      },
      {
        "id": "NCT05168813-774041bd",
        "title": "Part B (Blinded): mRNA-1273 at Month 6 vs Part B (Blinded): mRNA-1273.222 at Month 6: Part B: Number of Participants With a First Occurrence of COVE-based Severe COVID-19 Starting 14 Days After Month 6 Dose Until End of Follow up in RM6 Cohort Between Month 6 Monovalent and Bivalent Groups",
        "summary": "1 of 1976 against 0 of 2012; risk difference 0.1 points, 95% interval -0.1 to 0.3; NCT05168813, Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern",
        "record": "/library/comparisons/NCT05168813-774041bd",
        "nct_id": "NCT05168813",
        "kind": "outcome",
        "participants": 3988,
        "risk_difference": {
          "value": 0.0005060728744939271,
          "lower": -0.001444596914272216,
          "upper": 0.002861128099984624
        },
        "group_1": "1 of 1,976",
        "group_2": "0 of 2,012",
        "difference": "0.1 points",
        "interval": "-0.1 to 0.3",
        "trial_title": "Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=109",
  "request_id": "6a8SuAd_rLqJ7fap"
}